5-Methyl-2'-deoxycytidine (5mdC) 是 DNA 甲基转移酶 (如哺乳动物 5-C-MTase) 的内源性底物，依赖于 DNA 茎环结构形成而结合 DNA。5-Methyl-2'-deoxycytidine 通过作为甲基化标记引导 DNA 从头甲基化，在单链 DNA 中通过顺式作用激活相邻 CpG 位点的甲基化。5-Methyl-2'-deoxycytidine 通过招募甲基转移酶至特定染色质区域，调控 DNA 甲基化模式，影响染色质凝聚状态及基因表达，在植物细胞中其分布与细胞增殖、分化阶段相关。5-Methyl-2'-deoxycytidine 在增殖细胞中甲基化水平较低，在分化细胞中较高。
Duocarmycin A 是众所周知的抗肿瘤抗生素之一，是一种 DNA 烷基化剂，可有效地使 DNA 中富含 AT 的序列 3' 末端的腺嘌呤 N3 烷基化。Duocarmycin A 作为一种化学研究剂，通常导致 HLC-2 细胞凋亡，包括染色质浓缩，DNA 直方图模式中的亚 G1 积累，以及procaspase-3 和 9 水平的降低。
GNE-274 是 ER 降解剂 GDC-0927 的结构类似物，是一种非降解剂。GNE-274 在乳腺癌细胞系中不诱导 ER 的转换，作为 ER 的部分激动剂 (partial ER agonist) 发挥作用。GNE-274 增加了ER-DNA 结合位点的的染色质可进入性，而 GDC-0927 则没有。GNE-274 是一种有效的 ER 配体结合域 (LBD) 抑制剂。GNE-274 可用于癌症研究。
VPC-14228 是一种选择性靶向雄激素受体 DNA 结合域 (AR-DBD) 的抑制剂。VPC-14228 抑制 AR 与 DNA 的相互作用，从而阻断 AR 介导的转录激活。VPC-14228 不依赖核定位抑制，而是通过干扰 AR 与染色质的结合，抑制全长 AR 及剪接变体 AR-V7 的活性，且对 ER、PR 等其他核受体选择性较高。VPC-14228 可用于前列腺癌的研究。
组蛋白修饰是对组蛋白的一种共价翻译后修饰 (PTM) 过程，包括甲基化、磷酸化、乙酰化、泛素化、类泛素化等。一般来说，组蛋白修饰是在特定酶的催化下进行的，酶主要作用于组蛋白 N 末端氨基酸，包括赖氨酸、精氨酸、丝氨酸、苏氨酸、酪氨酸等。组蛋白的翻译后修饰可以通过改变染色质结构或招募组蛋白修饰剂来影响基因表达。组蛋白修饰在不同的生物学过程中发挥作用，如转录激活/失活、染色体装配和 DNA 损伤/修复等。组蛋白修饰失调会导致多种疾病的发生，包括肿瘤、自身免疫性疾病等。
糖尿病是以长期高血糖为特征的代谢疾病。主要有两种类型：I 型糖尿病（T1D）和 II 型糖尿病（T2D）。I 型糖尿病又称为青少年糖尿病或胰岛素依赖型糖尿病，是以胰腺中 β 细胞破坏，不能产生胰岛素为特征；而 II 型糖尿病又称为非胰岛素依赖性糖尿病，其特征为胰岛素分泌进行性障碍，靶组织对分泌的胰岛素敏感性降低，其中 II 型糖尿病是糖尿病中的主要形式。所有类型的糖尿病都可能导致身体许多部位出现并发症，并增加过早死亡的风险，可能的并发症包括肾功能衰竭、截肢、视力丧失和神经损伤等。
5-Methyl-2'-deoxycytidine (5mdC) 是 DNA 甲基转移酶 (如哺乳动物 5-C-MTase) 的内源性底物，依赖于 DNA 茎环结构形成而结合 DNA。5-Methyl-2'-deoxycytidine 通过作为甲基化标记引导 DNA 从头甲基化，在单链 DNA 中通过顺式作用激活相邻 CpG 位点的甲基化。5-Methyl-2'-deoxycytidine 通过招募甲基转移酶至特定染色质区域，调控 DNA 甲基化模式，影响染色质凝聚状态及基因表达，在植物细胞中其分布与细胞增殖、分化阶段相关。5-Methyl-2'-deoxycytidine 在增殖细胞中甲基化水平较低，在分化细胞中较高。
CHMP1B; C18orf2Charged multivesicular body protein 1b; CHMP1.5; Chromatin-modifying protein 1b; CHMP1b; Vacuolar protein sorting-associated protein 46-2; Vps46-2; hVps46-2
CHMP4B; Charged multivesicular body protein 4b; Chromatin-modifying protein 4b; CHMP4b; SNF7 homolog associated with Alix 1; SNF7-2; hSnf7-2; Vacuolar protein sorting-associated protein 32-2; Vps32-2; hVps32-2
CHMP4B; Charged multivesicular body protein 4b; Chromatin-modifying protein 4b; CHMP4b; SNF7 homolog associated with Alix 1; SNF7-2; hSnf7-2; Vacuolar protein sorting-associated protein 32-2; Vps32-2; hVps32-2
SMARCC1 Antibody (YA5256) is a mouse-derived and non-conjugated monoclonal antibody, targeting to SMARCC1. It can be applicated for WB assays, in the background of human.
p150 CAF1 Antibody (YA1488) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1488), targeting p150 CAF1, with a predicted molecular weight of 107 kDa (observed band size: 150 kDa). p150 CAF1 Antibody (YA1488) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.
ATP dependent helicase SMARCA4; ATP-dependent helicase SMARCA4; BAF 190; BAF190; BAF190A; Brahma protein homolog 1; Brahma protein like 1; BRG1; BRG1 associated factor 190A; BRG1 protein; BRG1-associated factor 190A; BRM/SWI2 related gene 1; Global transcription activator homologous sequence; global transcription activator snf2l4; Homeotic gene regulator; hSNF2b; Mitotic growth and transcription activator; MRD16; Nuclear protein GRB1; Protein brahma homolog 1; Protein BRG-1; Protein BRG1; RTPS2; SMARC A4; SMARCA4; SMCA4_HUMAN; SNF2; SNF2 beta; SNF2 like 4; SNF2-beta; SNF2B; SNF2L4; SNF2LB; Sucrose nonfermenting like 4; SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 4; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4; SWI2; Transcription activator BRG1.
WB, ICC/IF, IP
Human, Mouse
BRG1 Antibody (YA5293) is a mouse-derived and non-conjugated monoclonal antibody, targeting to BRG1. It can be applicated for WB, ICC/IF, IP assays, in the background of human, mouse.
SUZ12; CHET9; JJAZ1; KIAA0160; Polycomb protein SUZ12; Chromatin precipitated E2F target 9 protein; ChET 9 protein; Joined to JAZF1 protein; Suppressor of zeste 12 protein homolog
WB, ICC/IF, IP
Human, Mouse, Rat
SUZ12 Antibody (YA3185) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3185), targeting Polycomb Protein SUZ12, with a predicted molecular weight of 83 kDa (observed band size: 83 kDa). SUZ12 Antibody (YA3185) can be used for WB, ICC/IF, IP experiment in human, mouse, rat background.
SUZ12; CHET9; JJAZ1; KIAA0160; Polycomb protein SUZ12; Chromatin precipitated E2F target 9 protein; ChET 9 protein; Joined to JAZF1 protein; Suppressor of zeste 12 protein homolog
WB, ICC/IF, ELISA
Human
SUZ12 Antibody (YA5070) is a mouse-derived and non-conjugated monoclonal antibody, targeting to SUZ12. It can be applicated for WB, ICC/IF, ELISA assays, in the background of human.
SUZ12; CHET9; JJAZ1; KIAA0160; Polycomb protein SUZ12; Chromatin precipitated E2F target 9 protein; ChET 9 protein; Joined to JAZF1 protein; Suppressor of zeste 12 protein homolog
WB, IHC-P, ICC/IF, IP, ELISA
Human, Mouse, Rat
SUZ12 Antibody (YA6275) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Polycomb Protein SUZ12. It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.
SMARCA2; BAF190B; BRM; SNF2A; SNF2L2; Probable global transcription activator SNF2L2; ATP-dependent helicase SMARCA2; BRG1-associated factor 190B; BAF190B; Protein brahma homolog; hBRM; SNF2-alpha; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2
WB, IHC-F, IHC-P, ICC/IF
Human
SMARCA2 Antibody (YA3241) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3241), targeting SMARCA2, with a predicted molecular weight of 181 kDa (observed band size: 190 kDa). SMARCA2 Antibody (YA3241) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human background.
SMARCB1 Antibody (YA5649) is a mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to INI-1. It can be applicated for IHC-P, WB, ICC/IF, ELISA assays, in the background of human, mouse.
